Bringing the fundamentals into focus…
Bringing the fundamentals into focus…
THC · against 105 other Healthcare companies of similar size
Ranked #2 of 106 · scores higher than 98% of peers
Bars: peers in each 10-point band of the valuation score8 peers with a valuation score of 90–100, including THC · Click a bar to see the companies
Mainly thanks to its earnings yield, free cash flow yield and EBITDA yield, which are stronger than most Healthcare peers.
| Metric | THC | Peer median | Better than | Position among peers | Weight |
|---|---|---|---|---|---|
| Earnings yieldHigher is better · 104 reported | 9.7% | 3.2% | 99% | 30% | |
| EBITDA yieldHigher is better · 106 reported | 13.2% | 5.9% | 94% | 50% | |
| Free cash flow yieldHigher is better · 65 reported | 14.1% | 3.8% | 95% | 20% | |
| Book yieldHigher is better · 100 reported | 21.7% | 22.6% | 48% | Context only |
| Rank | Company | Market cap | Valuation | Overall |
|---|---|---|---|---|
| 1 | 89.5B HKD (≈$11.5B) | 98 | 67 | |
| 2 | 80.2B CNY (≈$11.2B) | 95 | 76 | |
| 2 | 21.5B USD | 95 | 60 | |
| 4 | 11.6B USD | 94 | 58 | |
| 4 | 68.0B BRL (≈$12.2B) | 94 | 67 | |
| 6 | 4.61T JPY (≈$31.3B) | 93 | 76 | |
| 7 | 11.6B USD | 92 | 57 |
Scores are sector-relative percentiles from the latest snapshot, always calculated against the whole sector: narrowing the comparison group changes who you compare with, not the scores. Missing metrics are left out and the remaining weights rescaled. How we score